# Phase 2/3 disease trials recruiting: 41 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 41 trials in phase 2/3 for disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2/3 disease trials: 41 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2-3/disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 41
- Recruiting or not yet: 41
- Read on: November 19, 2026

## Trials

The 25 newest of 41, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 28, 2026 | NCT07901244 | An Open-Label Study to Determine if BHV-1300 is Safe in Adults With Graves' Disease | Biohaven Therapeutics Ltd. | Phase 2/3 | Not yet recruiting | Graves' Disease | 356 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901244) |
| October 28, 2026 | NCT07900100 | Evaluating the Safety and Efficacy of Rupatadine in the Treatment of Nonalcoholic Fatty Liver Disease Patients. | Tanta University | Phase 2/3 | Not yet recruiting | NAFLD (Nonalcoholic Fatty Liver Disease) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900100) |
| October 28, 2026 | NCT07900087 | Evaluating the Safety and Efficacy of Roflumilast in the Treatment of Nonalcoholic Fatty Liver Disease Patients | Tanta University | Phase 2/3 | Not yet recruiting | NAFLD (Nonalcoholic Fatty Liver Disease) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900087) |
| October 21, 2026 | NCT07885917 | Long-Term Safety and Tolerability of Nizubaglustat in Participants With Rare Lysosomal Disorders | Azafaros B.V. | Phase 2/3 | Not yet recruiting | Niemann-Pick Disease Type C, GM2 Gangliosidosis, GM1 Gangliosidosis, Gaucher Disease Type 3 | 218 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885917) |
| August 26, 2026 | NCT07786922 | A Study of Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard... | Swedish Orphan Biovitrum | Phase 2/3 | Not yet recruiting | Aplastic Anemia | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07786922) |
| August 11, 2026 | NCT07757204 | An Open-label Long-term Safety Study of Buntanetap in Participants With AD | Annovis Bio Inc. | Phase 2/3 | Not yet recruiting | Alzheimer's Dementia (AD) | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07757204) |
| July 24, 2026 | NCT07725562 | VG081821AC Tablets for Early to Mid-stage Parkinson's Disease | Zhejiang Vimgreen Pharmaceuticals, Ltd. | Phase 2/3 | Recruiting | Parkinson Disease (PD) | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07725562) |
| June 2, 2026 | NCT07621939 | A Study of IMM0306 in IgG4-Related Disease | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | Phase 2/3 | Not yet recruiting | IgG4-Related Disease | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621939) |
| May 6, 2026 | NCT07571681 | Colchicine for Autoimmune and Subacute Thyroiditis | Mansoura University | Phase 2/3 | Recruiting | Hashimoto Thyroiditis, Subacute Thyroiditis, Thyroiditis | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07571681) |
| April 17, 2026 | NCT07535554 | The Investigators Will Evaluate the Diagnostic Performance of \[18F\]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the... | Universitaire Ziekenhuizen KU Leuven | Phase 2/3 | Recruiting | Fever of Unknown Origin, IgG4 Related Disease, Axial Spondylarthritis (axSpA), Inflammation of Unknown Origin | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07535554) |
| February 27, 2026 | NCT07440290 | DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF... | Cancer Research UK | Phase 2/3 | Recruiting | Haematological Malignancy, Malignant Neoplasm, Lymphoproliferative Disorders, Neoplasms by Histologic Type, Neoplasms... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07440290) |
| January 30, 2026 | NCT07378644 | Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease | Skyhawk Therapeutics, Inc. | Phase 2/3 | Recruiting | Huntington Disease | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07378644) |
| January 22, 2026 | NCT07359807 | A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in... | Concept Medical Inc. | Phase 2/3 | Not yet recruiting | Popliteal Artery Disease, Superficial Femoral Artery Disease | 478 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359807) |
| January 6, 2026 | NCT07319897 | 68Ga-BCMA PET/CT in Multiple Myeloma | Peking University First Hospital | Phase 2/3 | Recruiting | Multiple Myeloma, Multiple Myeloma and Malignant Plasma Cell Neoplasms, Multiple Myeloma and Plasma Cell Neoplasm | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07319897) |
| December 22, 2025 | NCT07297914 | Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL | Bambino Gesù Hospital and Research Institute | Phase 2/3 | Recruiting | Acute Lymphoblastic Leukemia (ALL), Stem Cell Transplant, Graft -Versus-host-disease | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07297914) |
| December 16, 2025 | NCT07284784 | A Study of Buntanetap in Participants With PD | Annovis Bio Inc. | Phase 2/3 | Recruiting | Parkinson's Disease (PD), Deep Brain Stimulation | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07284784) |
| November 17, 2025 | NCT07229664 | Vinpocetine in Patients With Parkinsonian Disease | Tanta University | Phase 2/3 | Recruiting | Parkinson Disease | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07229664) |
| November 17, 2025 | NCT07229651 | Metformin in Parkinson Disease | Tanta University | Phase 2/3 | Recruiting | Parkinson Disease | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07229651) |
| September 29, 2025 | NCT07196722 | A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Janssen Research & Development, LLC | Phase 2/3 | Recruiting | Crohn Disease | 1,092 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07196722) |
| August 1, 2025 | NCT07098598 | Pancreatic Cancer Diagnosis With FAPI-PET Imaging | Turku University Hospital | Phase 2/3 | Recruiting | Positron Emission Tomography, Pancreatic Cancer, FAPI, Diagnostics, Recurrent Pancreatic Cancer, Oncologic Surgery... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07098598) |
| July 16, 2025 | NCT07068165 | A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease | Peking Union Medical College Hospital | Phase 2/3 | Recruiting | IgG4 Related Disease | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07068165) |
| July 15, 2025 | NCT07066826 | Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of... | Wanbangde Pharmaceutical Group Co., LTD | Phase 2/3 | Recruiting | Alzheimer Dementia | 720 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07066826) |
| May 30, 2025 | NCT06996730 | A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment... | Banner Health | Phase 2/3 | Recruiting | Autosomal Dominant Alzheimers Disease, Early Onset Alzheimer Disease, Alzheimers Disease | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06996730) |
| May 16, 2025 | NCT06976268 | A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease | Biohaven Therapeutics Ltd. | Phase 2/3 | Recruiting | Parkinson Disease | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06976268) |
| May 9, 2025 | NCT06964230 | A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects | T3D Therapeutics, Inc. | Phase 2/3 | Not yet recruiting | Alzheimer's Disease | 376 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06964230) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Tanta University | 5 |
| [Chiesi Farmaceutici S.p.A.](https://specstream.ai/data/clinical-trials/company/chiesi-farmaceutici-s-p-a) | 2 |
| Cancer Research UK | 2 |
| Annovis Bio Inc. | 2 |
| [Biohaven Therapeutics Ltd.](https://specstream.ai/data/clinical-trials/company/biohaven-therapeutics-ltd) | 2 |
| Washington University School of Medicine | 2 |
| Peking University First Hospital | 1 |
| [Swedish Orphan Biovitrum](https://specstream.ai/data/clinical-trials/company/swedish-orphan-biovitrum) | 1 |
| Skyhawk Therapeutics, Inc. | 1 |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
| Banner Health | 1 |
| T3D Therapeutics, Inc. | 1 |
| Mansoura University | 1 |
| Turku University Hospital | 1 |
| VA Office of Research and Development | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Sling Therapeutics, Inc. | 1 |
| Wanbangde Pharmaceutical Group Co., LTD | 1 |
| Hospital Regional de Alta Especialidad del Bajio | 1 |
| [CSL Behring](https://specstream.ai/data/clinical-trials/company/csl-behring) | 1 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 1 |
| Ottawa Heart Institute Research Corporation | 1 |
| Zhejiang Vimgreen Pharmaceuticals, Ltd. | 1 |
| Concept Medical Inc. | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 14 |
| United Kingdom | 9 |
| Egypt | 6 |
| China | 6 |
| Canada | 6 |
| Germany | 6 |
| Spain | 6 |
| France | 6 |
| Argentina | 5 |
| Australia | 5 |
| Italy | 5 |
| Netherlands | 5 |
| Belgium | 4 |
| Colombia | 4 |
| Mexico | 4 |
| South Korea | 4 |
| Japan | 3 |
| Brazil | 3 |
| Austria | 3 |
| Norway | 3 |
| Czechia | 3 |
| Denmark | 3 |
| Israel | 3 |
| Poland | 3 |
| Puerto Rico | 3 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Foundation repair contractors in the United States](https://specstream.ai/data/businesses/foundation-repair-contractors/united-states)
- [Spine surgery practices in the United States](https://specstream.ai/data/businesses/spine-surgery-practices/united-states)
- [Educational supply stores in the United States](https://specstream.ai/data/businesses/educational-supply-stores/united-states)
- [Pubs in the United States](https://specstream.ai/data/businesses/pubs/united-states)
- [Colleges and universities in the United States](https://specstream.ai/data/businesses/colleges-and-universities/united-states)
- [Patent law firms in the United States](https://specstream.ai/data/businesses/patent-law-firms/united-states)
